Yahoo Finance EN

UBS and BofA Lift Price Targets on Viatris (VTRS)

Mar 13, 2026 &03351313202631; 18:35 UTC finance.yahoo.com

Read original on finance.yahoo.com ↗

↗

Positive for markets

Sentiment score: +65/100

Moderate impact Short-term (days)

WHAT THIS MEANS

UBS and Bank of America have raised their price targets on Viatris (VTRS), signaling improved confidence in the pharmaceutical company's outlook and potential upside. This analyst upgrade reflects positive sentiment toward the stock's valuation and future performance prospects.

AI CONFIDENCE

75% High

SENTIMENT GAUGE

NEWS POWER SCORE

AFFECTED ASSETS

↑

VTRS

VTRSStock

Expected to rise

Price target increases from major investment banks UBS and BofA indicate positive reassessment of company fundamentals and growth prospects

PRICE HISTORY

Loading chart...

⚡ SUGGESTED ACTION

Consider accumulating VTRS on any near-term weakness as the analyst upgrades provide technical support. Monitor for follow-up analyst coverage from other major institutions that could amplify the bullish momentum.

KEY SIGNALS

Analyst price target upgrade from two major banksIncreased institutional confidence in VTRS valuationPotential catalyst for near-term stock appreciationPositive sentiment shift in pharmaceutical sector coverage

SECTORS INVOLVED

HealthcarePharmaceuticals

Analysis generated on Mar 16, 2026 at 13:31 UTC

Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Yahoo Finance. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

UBS and BofA Lift Price Targets on Viatris (VTRS)

RELATED INTELLIGENCE